Abeona Therapeutics Inc [ABEO] stock prices are up 2.52% to $5.70 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ABEO shares have gain 3.35% over the last week, with a monthly amount glided 18.50%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Abeona Therapeutics Inc [NASDAQ: ABEO] stock has seen the most recent analyst activity on July 03, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $15. Previously, Stifel started tracking the stock with Buy rating on May 30, 2024, and set its price target to $21. On November 11, 2020, upgrade upgraded it’s rating to Overweight but maintained its price target of $4 on the stock. B. Riley FBR started tracking the stock assigning a Buy rating and suggested a price target of $5 on September 18, 2020. SVB Leerink initiated its recommendation with a Outperform and recommended $6 as its price target on February 10, 2020. In a note dated August 15, 2019, Maxim Group downgraded an Hold rating on this stock.
The stock price of Abeona Therapeutics Inc [ABEO] has been fluctuating between $3.05 and $9.01 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Abeona Therapeutics Inc [NASDAQ: ABEO] shares were valued at $5.70 at the most recent close of the market. An investor can expect a potential return of 5.26% based on the average ABEO price forecast.
Analyzing the ABEO fundamentals
The Abeona Therapeutics Inc [NASDAQ:ABEO] reported sales of 0.00M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -0.37% with Operating Profit Margin at -20.09%, Pretax Profit Margin comes in at -18.63%, and Net Profit Margin reading is -18.63%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -2.08 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.55 points at the first support level, and at 5.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.80, and for the 2nd resistance point, it is at 5.90.
Ratios To Look Out For
It’s worth pointing out that Abeona Therapeutics Inc [NASDAQ:ABEO]’s Current Ratio is 7.48. As well, the Quick Ratio is 7.48, while the Cash Ratio is 2.04.
Transactions by insiders
Recent insider trading involved Alvino Mark, Director, that happened on Jun 18 ’24 when 25890.0 shares were sold. Director, Silverstein Christine Berni completed a deal on Jun 18 ’24 to sell 25821.0 shares. Meanwhile, Director Alland Leila bought 11000.0 shares on May 16 ’24.
